Serina Therapeutics, Inc.

US$1.38As of Sun 8 Nov 2026, 12:00 UTC
AMEX:SERHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (58.27%)
Div yield —
ROE (207.94%)
Biotechnology
Beta (5Y) 0.15
PE TTM —
TSR TTM (72.40%)
Mkt cap US$35.05M
ROIC (130.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.72
24.90%
(43.80%)
Hold 10|2|8|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.02
0.02
0.02
16.59%
20.71%
24.44%
16.39%
Revenue$M
2.878
2.987
2.929
2.951
6.95%
11.60%
10.35%
6.45%
Peers (US$35.05M)
Cap (US$)
PE
35.03M
61.89x
34.75M
—
Capital
TTM
5Y
10Y
Leveragex
0.550
0.014
0.010
EBIT/Intx
0.271
0.127
0.118
Own earn%
17.05
13.96
9.37
Sh yield%
44.07
55.74
54.05
Owners
Insiders/Inst%
9.79
74.13
Short interest%
1.42
SBC / revenue%
4.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
10–20
$1 testx
—
Incr. ROIC%
9